Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 2

INTRODUCTION 1.2 MARKET DEFINITION • Human insulin is the class of biosynthetic product that is manufactured from bacteria (such as Escherichia coli) by recombinant DNA technology. The synthetic insulin prepared by rDNA method is either structurally same (human insulin biologics) or similar (human insulin biosimilars) as that of naturally occurring insulin in humans. • Furthermore, human insulin products covered under the study scope of the human insulin market includes human insulin drugs (biologics & biosimilars, including generic drugs) as well as delivery devices that are used for human insulin administration. However, human insulin market scope includes syringes, pens, and pen needles, and does not cover other human insulin delivery devices such as human insulin pumps, patches, and inhalation devices. 1.3 MARKET SCOPE 1.3.1 MARKETS COVERED • This research report categorizes the global human insulin market into the following segments: •                                              • • [email protected] www.marketsandmarkets.com 2